Sources: EQT Partners to team with Actavis in Ratiopharm bid

EQT Partners AB, the last private-equity bidder for German generic-drug maker Ratiopharm GmbH, is seeking to team up with Actavis Group to bolster its chances of beating large pharmaceutical companies like Pfizer in the auction, said three people familiar with the matter. Report